Date | Title | Description |
20.07.2023 | Tillotts Pharma and TVM Capital Life Science Announce Format... | Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Novel antibody specifi... |
17.03.2023 | TVM Capital Life Science to participate in LSI USA ’23 Emerg... | Montreal, Canada / Munich, Germany – 17 March 2023 – TVM Capital Life Science (“TVM”), a leading int... |
23.02.2023 | TVM Capital Life Science Announces Promotions to Recognize S... | Montreal, Canada / Munich, Germany – 23 February 2023 – TVM Capital Life Science (“TVM”), a leading ... |
21.02.2023 | Esperas Pharma, Inc. Announces Investment from TVM Life Scie... | Montréal, Québec, February 21, 2023 – Esperas Pharma, Inc. (“Esperas”), a company based in Montréal,... |
08.02.2023 | TVM Capital Life Science Announces Creation of LAmAb Biologi... | LAmAb Biologics to develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE... |
01.02.2023 | TVM Capital Life Science announces up to USD 24 million inve... | Recurv is the 8th early-stage or product focused company (PFC) investment for TVM Life Science Innov... |
18.12.2022 | TVM Capital Winter Conference | Dear Friends and Partners of TVM Capital Life Science.
We have decided to cancel the 2023 TVM Winte... |
01.08.2022 | Panthera D-SAD Classic oral appliance now eligible for Medic... | Quebec, Canada, July 28, 2022. Panthera Dental (Quebec, Canada), a global leader in CAD/CAM implant ... |
23.06.2022 | Kent Imaging Recognized as Most Innovative Medical Imaging T... | SnapshotNIR is enabling clinicians to drive better outcomes in wound care, limb preservation, and su... |
29.03.2022 | Egg Medical hatches technology to shield health care workers... | The Arden Hills company has landed $13 million in financing.
By Burl Gilyard Star Tribune MARCH 27,... |
15.03.2022 | Egg Medical hatches $13M VC funding |
March 4, 2022
By Annette Boyle
Egg Medical Inc. secured a $13 million investment from TVM Capita... |
03.03.2022 | Egg Medical, Inc., Closes on $13 million Financing |
Egg Medical, Inc., Closes on $13 million Financing
Arden Hills, MN (March 3rd, 2022) — Egg Medica... |
08.02.2022 | CENTOGENE Announces CFO Transition and Appointment of Miguel... | CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V... |
01.02.2022 | CENTOGENE Announces Nomination of Andreas Busch to Superviso... | CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene N.V.... |
01.02.2022 | CENTOGENE Announces Nomination of Kim Stratton as Chief Exec... | CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene N.V.... |
01.02.2022 | CENTOGENE Announces USD 62 Million Aggregate Equity and Debt... | CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 1, 2022 (GLOBE NEWSWIRE – Centogene N.V.... |
18.01.2022 | TVM Capital Life Science promotes Dr. Sascha Berger and Dr. ... | Munich, Germany / Montreal, Canada – 12 January 2022 – TVM Life Science (“TVM”),
a leading Internati... |
13.01.2022 | Syndivia and TVM Capital Life Science Announce Creation of A... | Luxembourg, January 13th, 2022 – TVM Life Science Innovation II SCSp announced the Fund’s investment... |
22.11.2021 | Acer Therapeutics Reports Q3 2021 Financial Results and Prov... | NEWTON, MA – Nov. 19, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused... |
16.11.2021 | Kent Imaging – Setting A New Global Standard in Advanced Tis... | November 16, 2021
Kent Imaging is a market leader in light-based tissue assessment diagnostic devic... |
16.11.2021 | Nekonal and TVM Capital Life Science Announce Creation of T7... | Luxembourg, November 15th, 2021 – TVM Life Science Innovation II SCSp announced the Fund’s investmen... |
08.10.2021 | Acer Therapeutics Receives Notice of Allowance of Key U.S. P... | Notice of allowance of ACER-001 formulation composition of matter patent application strengthens pro... |
08.10.2021 | CENTOGENE and Twist Bioscience to Develop Advanced Sequencin... | CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and SOUTH SAN FRANCISCO, Calif., Oct. 06, 2021 (GLO... |
15.07.2021 | Rapid Micro Biosystems Announces Pricing of Initial Public O... | Source: Rapid Micro Biosystems, Inc.
July 14, 2021 21:30 ET
LOWELL, Mass., July 14, 2021 (GLOBE NEWS... |
27.05.2021 | Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 20... | NEWTON, MA and GENEVA, SWITZERLAND – May 25, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER)(“Acer”), a... |
25.03.2021 | COVID Innovations March 25th, 2021 | Author: Dr. Linda Morrow – March 25th, 2021
Imagine a pandemic without having to shut down our live... |
22.03.2021 | Relief and Acer Therapeutics Sign Collaboration and License ... | Relief to potentially pay Acer up to $36 million and royalties in exchange for net profit share and ... |
04.03.2021 | Access Vascular, Inc. Secures $20 Million in Series B Financ... | Bedford, MA – 03 March, 2021-
Access Vascular, Inc., a company addressing the most common and costl... |
25.02.2021 | Kent’s deal with Net Health to expand Snapshot’s footprint... | By David Godkin, Staff Writer
TORONTO – Think of it. More than 14,000 facilities boasting 98% of the... |
01.02.2021 | TVM Life Science Innovation II SCSp Announces Investment in ... | Luxembourg, February 1st, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s inves... |
01.02.2021 | TVM Life Science Innovation II SCSp Announces Investment in ... | Luxembourg, February 1st, 2021 – TVM Life Science Innovation II SCSp today announced the Fund’s inve... |
19.01.2021 | TVM Life Science Innovation II SCSp Announces Investment in ... | Luxembourg, January 19th, 2021 –TVM Life Science Innovation II SCSp today announced the fund’s inves... |
14.01.2021 | Kent Imaging Inc. is accelerating its growth through a US$15... | CALGARY, AB, CANADA, January 13, 2021
/EINPresswire.com/ — Kent Imaging, an innovator in the tissue... |
07.01.2021 | Emovi and SIAwards: 2nd interview on KneeKG and knee pain | The interview was live just before the award to Lebron James!
The interview also presents Dr Michae... |
13.11.2020 | Dentsply Sirona and Panthera Dental announce collaboration: ... | (Charlotte/Quebec, November 12, 2020)
Dentists now have the opportunity to use Primescan in a new a... |
27.10.2020 | TVM Capital Life Science Announces Substantially Oversubscri... | Munich/Montreal: October 27, 2020 – TVM Capital Life Science, one of the leading life sciences ventu... |
22.10.2020 | CENTOGENE Announces Leadership Transition | CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, October 20, 2020
(GLOBE NEWSWIRE) —
Centogene N.... |
15.07.2020 | CENTOGENE Announces Pricing of Primary and Secondary Public ... | CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 9, 2020
(GLOBE NEWSWIRE) — Centogene N.V. (N... |
10.07.2020 | CENTOGENE Announces Proposed Primary and Secondary Public Of... | CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (N... |
08.04.2020 | Centogene öffnet seine Labore für Coronatests | Verantwortung in Krisenzeiten: Ein Rostocker Unternehmen, das sonst seltenen Krankheiten auf der Spu... |
03.04.2020 | Panthera employees in Quebec City have been hard at work man... | (Montreal, March 24, 2020) Across Quebec, 3D printing companies are active in the fight against the ... |
24.03.2020 | Centogene Announces Commencement of Testing for COVID-19 | Cambridge, MA, USA & Rostock/Berlin, Germany, March 18, 2020 (GLOBAL NEWSWIRE) – CENTOGENE (Nasd... |
04.02.2020 | La Presse: “Laurent Duvernay-Tardif’s knees at their best th... | “Unless he is injured during the game on Sunday, Laurent Duvernay-Tardif will be solid on both knees... |
15.11.2019 | CENTOGENE Signs Data Access and Collaboration Agreement with... | Accelerating new rare disease therapies through collaboration agreement
Cambridge, MA, USA & Ro... |
08.11.2019 | Centogene AG Rings The Nasdaq Stock Market Closing Bell in C... | - |
29.10.2019 | CENTOGENE Announces Proposed Initial Public Offering of Comm... | October 28, 2019 at 8:53 AM EDT
CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIR... |
18.10.2019 | Neurimmune and TVM Capital Life Science Announce the Initiat... | Schlieren, Switzerland – October 16, 2019 – AL-S Pharma AG, a biotech company jointly founded and fi... |
14.10.2019 | Lilly’s REYVOW™ (lasmiditan), The First and Only Medicine in... | The approval of REYVOW is significant because it represents the first new class of acute migraine tr... |
02.10.2019 | Emovi Announces Results of Clinical Trial to Manage Knee Ost... | Results demonstrates that use of KneeKG in patients with osteoarthritis reduces pain, improves patie... |
25.09.2019 | Proteon Therapeutics and ArTara Therapeutics Agree to Combin... | September 23, 2019
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Compa... |
17.09.2019 | BIO Deutschland – Biotechnologie-Branchenverband wählt Dr Hu... | Berlin (17. September 2019) – Der Branchenverband der Biotechnologie-Industrie, BIO Deutschland e. V... |
24.06.2019 | We are very proud to have won the Deal of The Year Award 201... | The Canadian Venture Capital and Private Equity Association (CVCA) announced the winners of its annu... |
28.05.2019 | CENTOGENE Welcomed Germany’s Chancellor Dr. Angela Merkel | CENTOGENE welcomed Germany’s Chancellor Dr. Angela Merkel on May 23, 2019 to its headquarters togeth... |
02.04.2019 | CENTOGENE announces the appointment of Dr. Flemming Ornskov ... | Rostock/Berlin, Germany, 2 April, 2019 – CENTOGENE announced today that Dr. Flemming Ornskov has bee... |
04.03.2019 | Emovi is accelerating its growth through a 15M$ Series C inv... | Photo: Emovi
MONTREAL, March 4, 2019 /CNW Telbec/ – Emovi announced today its partnership with TVM ... |
02.01.2019 | Please use our dedicated page for Funding Requests! | We have added a new page to the website to ensure timely processing of your funding requests. Please... |
17.10.2018 | 1. Tiroler Biotech Konferenz an der UMIT: „Where Life Scienc... | Einzigartige Initiative von privatem Risikokapital und öffentlicher Hand unter Beteiligung des Lande... |
03.10.2018 | CENTOGENE and DENALI THERAPEUTICS announce strategic collabo... | CENTOGENE and Denali Therapeutics (NASDAQ: DNLI) today announced a strategic collaboration for the g... |
07.06.2018 | F-star Announces Early Exercise by Denali Therapeutics of it... | Cambridge, UK, 30 May 2018 – F-star, a clinical-stage biopharmaceutical company developing novel bis... |
14.05.2018 | Lilly to Acquire AurKa Pharma | Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor T... |
08.05.2018 | Rapid Micro Biosystems Secures $60 Million In Equity Financi... | Investment to Accelerate Company’s Continued Global Commercial Expansion and Product Innovation
Low... |
13.04.2018 | Deinove To Acquire Biovertis/Morphochem | Deinove Gains Access to Biovertis/Morphochem’s Lead Compound MCB3837 for the Potential Treatment of ... |
19.03.2018 | Prof. Arndt Rolfs joins newly formed “Global Commission to E... | Prof. Arndt Rolfs, CENTOGENE AG, has joined newly formed “The Global Commission to End the Diagnosti... |
13.11.2017 | Norgine Ventures completes €2 million financing with pritide... | LONDON, UK. 7 November 2017, 08:35 AM GMT. Norgine Ventures announced today that it has provided fin... |
05.11.2017 | Meet us at BIO-EUROPE! |
We are happy and honored sponsors of this year’s BIO-EUROPE in Berlin, taking off on Monday, Novem... |
25.10.2017 | TVM Capital Life Science exits invendo medical GmbH | Ballerup, Denmark and Kissing, Germany, October 25, 2017 – Today, Ambu A/S – a leader in the develop... |
04.10.2017 | Panthera Dental is accelerating its growth through investmen... | Quebec City, October 3, 2017
Panthera Dental announced today itspartnership with TVM Life Science V... |
20.09.2017 | TVM Capital Life Science hosts its 6th annual Life Science C... | Montreal, September 19, 2017
TVM Capital Life Science convened its 6th annual Autumn Conference in ... |
04.07.2017 | Acer Therapeutics and Opexa Therapeutics Sign Merger Agreeme... | Merger to create a pre-NDA-stage, NASDAQ-listed, pharmaceutical company focused on the development a... |
23.06.2017 | Proteon Therapeutics Announces $22.0 Million Private Placeme... | Provides Sufficient Cash into Q4 2019
WALTHAM, Mass., June 22, 2017 (GLOBE NEWSWIRE) — Proteon Ther... |
13.06.2017 | CENTOGENE raises a EUR 25 million Series A financing to fuel... | Rostock/Berlin, 13.06.2017 – CENTOGENE AG, a worldwide leader in the field of genetic diagnostics fo... |
04.06.2017 | Proteon Therapeutics Receives FDA Breakthrough Therapy Desig... | WALTHAM, Mass., May 10, 2017 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company ... |
17.05.2017 | Attraktiv für Investoren! Individualisierte Medizin ist scho... | Eine große Zahl von VC Investitionen im Life Science Bereich und deren Innovation sind implizit Inve... |
09.05.2017 | NOXXON PHARMA secures a private placement of 1 million Euro ... | Berlin, Germany, May 2, 2017 – NOXXON Pharma N.V. (Alternext Paris: ALNOX), a biotechnology company ... |
23.03.2017 | Lilly and CoLucid Pharmaceuticals Announce Agreement for Lil... | $960 million deal will enhance Lilly’s existing pain management portfolio for migraine; adds potenti... |
09.01.2017 | leon Appoints Pharma Expert Michael Mehler as Chief Executiv... | leon nanodrugs GmbH appoints pharma expert Michael Mehler, Sc.D. as new CEO of the Munich based comp... |
07.12.2016 | Neurimmune and TVM Capital Life Science Announce Creation of... | Schlieren, Switzerland, and Munich, Germany, December 07, 2016 / B3C newswire / — Neurimmune and TVM... |
05.12.2016 | Pfizer Ventures and TVM Life Science Ventures VII Announce A... | London, UK, December 05, 2016 / — Pfizer Venture Investments (PVI) and TVM Life Science Ventures VII... |
05.12.2016 | NOXXON PHARMA ANNOUNCES NEW PRECLINICAL DATA SHOWING SYNERGY... | Poster Title: CXCL12 Inhibition by NOX-A12 (Olaptesed Pegol) Synergizes With the ADCC Activity of CD... |
04.11.2016 | Albireo Completes Transaction with Biodel to Create Publicly... | November 3, 2016
— Albireo Pharma, Inc. to trade on The NASDAQ Capital Market under symbol “ALBO” —... |
04.11.2016 | Funding the funders: Insight into the funders of VC healthca... |
Cologne Conference Center
Date: November 7, 2016
Time: 16:00 – 17:00
Stream: Main agenda, Level... |
19.09.2016 | TVM Life Science Ventures VII Announces Investment in AurKa ... | Montréal, Québec, September 19th, 2016 –TVM Life Science Ventures VII today announced the fund’s twe... |
07.09.2016 | invendo medical Announces FDA Clearance of the invendoscopy ... | A Simple, Safe and Effective Solution to the Challenges of Cross-Contamination and Infection Control... |
06.09.2016 | CoLucid Pharmaceuticals Announces Achievement of Both Primar... | Cambridge, MA, September 6, 2016 — CoLucid Pharmaceuticals, Inc., a biopharmaceutical company that i... |
10.08.2016 | CoLucid Pharmaceuticals Announces 2016 Second Quarter Result... | CAMBRIDGE, MA – August 10, 2016 – CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) today reported financ... |
25.07.2016 | FDA grants QIDP and Fast Track Designations to MCB3837, Morp... | Munich (Germany), July 25, 2016 — Morphochem, a clinical-stage pharmaceutical company, announced tod... |
22.06.2016 | Morphochem’s Investigational New Drug (IND) application acce... | Munich, Germany, June 22, 2016 — Morphochem, a private clinical-stage pharmaceutical company, announ... |
21.06.2016 | TVM Life Science Ventures VII Announces Investment in Mediti... | Montréal, Québec, June 20, 2016 – TVM Life Science Ventures VII closed the fund’s eleventh investmen... |
09.06.2016 | CoLucid Pharmaceuticals Announces Last Patient Randomized in... | CAMBRIDGE, Mass., June 07, 2016 (GLOBE NEWSWIRE) — CoLucid Pharmaceuticals, Inc. (Nasdaq:CLCD), a Ph... |
27.05.2016 | Biodel Inc. and Albireo Limited Agree to Combine | May 24, 2016
Conference call on Wednesday, May 25, 2016 at 8:30 a.m. ET
Danbury, CT and Boston, MA... |
27.05.2016 | CoLucid Pharmaceuticals Announces Initiation of Second Phase... | CAMBRIDGE, Mass., May 19, 2016 (GLOBE NEWSWIRE) — CoLucid Pharmaceuticals, Inc., a Phase 3 clinical-... |
14.04.2016 | Esperas Pharma Inc. will begin clinical development of a new... | Montréal, Québec, April 11 2016 – Esperas Pharma Inc. (“Esperas”) today announced the initiation of ... |
02.03.2016 | CoLucid Pharmaceuticals Announces Special Protocol Agreement... | CAMBRIDGE, MA – March 1, 2016 – CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD), a Phase 3 clinical-sta... |
01.02.2016 | TVM Life Science Ventures VII Announces Investment in Modula... | Montréal, Québec, February 1st, 2016 –TVM Life Science Ventures VII today announced the fund’s ninth... |
25.01.2016 | TVM Capital Life Science portfolio company Ixchelsis Ltd ann... | January 25, 2016 -Sandwich, UK. – Ixchelsis Ltd, a UK based biotech company, announced today that it... |
11.12.2015 | Watch the BIO-Europe Session on external innovation strategi... | We are proud to have hosted one of the best attended panel discussions at BIO-Europe this year, mode... |
23.09.2015 | Quebec Minister of finance, Carlos J. Leitao, held the Keyno... | Montréal, Québec, September 22st, 2015 –TVM Capital Life Science yesterday held its 4th annual TVM C... |
27.07.2015 | leon-nanodrugs GmbH raises EUR 18.5 million in Series A fina... | TVM Capital Life Science leads international syndicate of investors – an additional EUR 3 million in... |
17.07.2015 | Argos Therapeutics Announces Completion of Patient Enrollmen... | Fully Personalized Immunotherapy is Being Evaluated in Combination With Standard Targeted Therapy fo... |
15.06.2015 | Probiodrug receives 2015 European Mediscience Award for Best... | HALLE/SAALE, Germany, 12 June 2015 – Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical co... |